Paras Healthcare IPO GMP ₹85 Today (15 Oct), Price Band, Allotment Date

Paras Healthcare IPO Review & Analysis

Our reading of the numbers below — growth rates, margins, pricing and demand are calculated from the company's own filed figures, not copied from anywhere.

Paras Healthcare is a mainboard issue raising ₹1,450 Cr, offered in a band of ₹660–₹693 per share. At the upper end that is 693 times the ₹1 face value, so ₹692 of every share subscribed is share premium rather than capital.

A retail application for Paras Healthcare needs one lot of 21 shares, which works out to ₹14,553 at the upper band of ₹693. That is close to the ₹15,000 ceiling SEBI expects for a single retail lot, so an investor applying at cut-off is committing nearly the full retail limit per application. Retail applications are capped at ₹2,00,000, which here is 13 lots; bidding above that moves the application into the non-institutional category, and the large-HNI bucket begins at ₹10,00,000, or about 69 lots.

For Paras Healthcare, bidding runs 21-23 October, allotment is finalised on 26 Oct 2026, the shares list on 28 Oct 2026. Applications that do not receive an allotment have their UPI mandate released around 3 days after the issue closes. Counting from the close of bidding, money stays blocked for roughly 5 days before listing decides what the holding is worth.

The issue is reserved 75% to qualified institutional buyers, 15% to non-institutional investors, 10% to retail. At 10%, the retail portion is on the narrower side, so retail allotment turns into a lottery quickly once the book fills. An oversubscribed retail portion is not allotted in proportion to the amount applied for: applications are reduced to single lots and drawn by lot, so several small applications from different PANs are more effective than one large one.

The issue splits into ₹500 Cr of fresh capital (34.5%) and ₹950 Cr as an offer for sale. The company keeps the fresh portion for the objects of the issue, while the rest is existing shareholders monetising their stake.

The most recent figures the company has filed cover 30 Jun 2026, which is a different length of period from 31 Mar 2026. Year-on-year growth is not stated here because the two periods are not comparable — read the reported numbers side by side rather than as a growth rate.

Recently listed companies in the same space trade at a median price-to-earnings ratio of about 45.4. Comparing that with the multiple implied by this issue's ₹660–₹693 band is a more useful test of pricing than looking at the grey market premium alone.

MUFG Intime India Pvt.Ltd. is the registrar for this issue, which means the allotment status for Paras Healthcare is published on their portal from 26 Oct 2026. A PAN, application number or demat client ID is enough to look it up; the credited shares also appear in the demat account itself a day or so before listing.

A grey market premium of ₹85 on the upper band of ₹693 implies a listing gain of roughly 12.3%. The grey market is unofficial and unregulated, the premium can change daily, and it has no bearing on allotment — treat it as a sentiment reading, not a forecast.

The figures above are worked out from the issue's own filed numbers and are for information only. They are not investment advice — read the RHP before you apply.